|Articles|March 1, 2010
- BioPharm International-03-01-2010
- Volume 23
- Issue 3
BioPharm International, March 2010 Issue (PDF)
Best Practices for Characterizing Formulation Design
Advertisement
Articles in this issue
over 15 years ago
India's Future as a Biologics Manufacturing Hubover 15 years ago
Downstream Processing: Promising Technologies are on the Horizonover 15 years ago
Corrective and Preventative Action Programs: A Mechanism of Controlover 15 years ago
Characterizing the Formulation Design Spaceover 15 years ago
FDA Seeks More Timely Drug Information Electronicallyover 15 years ago
Quality Considerations for Peptide Manufacturing Processesover 15 years ago
Lessons from the War on TerrorismNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Trends in Formulation eBook October 2025
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
4
Analytics, Automation, and Quality Driving the Next Era of Drug Development
5
